Ceftazidime–avibactam tied to better early ICU survival in resistant Klebsiella, but benefit fades after adjustment
A retrospective ICU cohort study of 249 patients found lower unadjusted mortality with ceftazidime–avibactam for carbapenem-resistant Klebsiella pneumoniae, but the ...
